Fosfomycin FOM, 2g/day, was administered orally to 25 patients of acute or chronic sinusitis paranasalis and acute exacerbation. The following results were obtained from clinical and laboratory examinations.
1) Eleven patients were evaluated at the fourteenth day, according to the unified criteria. According to the physicians' evaluation, excellent results were seen in 3 patients, good results in 8. According to the unified criteria for judgment, excellent results were seen in 7 patients, good in 3 and moderate in 1 with respect to improvement in subjective and objective symptoms, and in terms of X-ray findings, an excellent result was seen in 1, good in 5, moderate in 2 and poor in 3. Improvement in X-ray findings was inferior to that of subjective and objective symptoms. Microorganisms isolated disappeared in 9 but different microorganisms appeared in 2 patients.
2) Fourteen patients were evaluated at seventh day. According to the physicians' evaluation, excellent results were obtained in 5, good in 1, moderate in 6 and poor in 2. According to the unified criteria for judgment, excellent results were found in 4, good in 4, moderate in 4 and poor in 2. Eight cases were evaluated for microorganisms. Isolated microorganisms disappeared completely in 6, and different microorganisms appeared in 2. The clinical results of these 14 patients were inferior to those of the patients who received administration for 14 days.
3. The MICs against Haemohilus influenzae, Streptococcus pneumoniae and Staphylococcus aureus were in the ranges of 1.56-6.25, 3.13-6.25 and 1.56-12.5μg/ml, respectively. And the MICs against Streptococcus pyogenes and Klebsiella pneumoniae were 3.13, 25μg/ml, respectively. Fosfomycin was effective in four organisms which caused sinusitis paranasalis, except Klebsiella pneumoniae.
4. The peak values of FOM in the serum and tissue were 6.3μg/ml and 4.1μg/ml, 2 hours and 15 minutes after administration of 1g of FOM.
5. As to the side effects of FOM, diarrhea was noted in 6 of the 24 patients. Diarrhea started 2 to 5 days after administration. Regarding laboratory findings, slight elevation of s-GPT was observed in 2 of the 11 patients.
View full abstract